We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The GMP Letter: Subscribe Now!
Email
Tweet

The GMP Letter: Subscribe Now!

Subscribe Now - Single-User

The GMP Letter

You’ve probably wished you had access to the inner workings of the FDA. A trusted friend in the organization with deep insight into FDA’s interpretation and enforcement of cGMPs and quality systems regulation. You’d turn to this person often for valuable information to help you stay in compliance and maintain — or increase — your competitive edge.

The GMP Letter is your go-to resource. GMP has the insights and information you can rely on to ensure your processes, procedures and controls are compliant.

Each month, The GMP Letter’s executive briefings bring you the latest on:

  • FDA’s approach to facility inspections such as the agency’s increasing focus on data security
  • Changes to the EU’s inspections for MDR compliance
  • Joint recognition of GMP inspections in the U.S., EU and other jurisdictions
  • Quality regulations and guidances for instance on cybersecurity and data integrity
  • And much more…

For the past 30 years, devicemakers who have relied on The GMP Letter have had much-needed information and analysis, enabling them to act swiftly to adjust manufacturing processes.

Bonus! You’ll also receive critical documents including 483s, warning letters, closeout letters, FDA policy notices and more.

Start your single-user one-year subscription (12 issues) to The GMP Letter for only $1,085. You’ll immediately gain access to the latest issue as well as a searchable database of 30 years of past issues.

Also available: Take advantage of our multi-user and site licenses of The GMP Letter, so you’ll have the most-informed workforce! Contact Bailey Sterrett, Director, BD at bsterrett@wcgclinical.com or +1 703.538.7637 to receive a custom quote.

We’re confident the value GMP provides you will pay for itself many times over. If you disagree, there’s our 100% Money-Back Guarantee.

Upcoming Events

  • 04Apr

    Optimizing Quality Control Operations with Unified Quality

  • 20Apr

    Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • FDA Deems Cardiosave Intra-Aortic Balloon Recall Class I

  • Xtandi Shows Promise in Prostate Cancer Trial

  • Implantable Sleeve that Holds Spinal Screws in Place Gets FDA Clearance

  • FDA Green Lights Clinical Trial of Low-Dose Psilocybin

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing